According to recent diagnostic criteria of 2023 internaltional consensus (3), MOGAD clinically presents with diverse manifestations including, optic neuritis (ON), transverse myelitis, acute disseminated encephalomyelitis (ADEM), and cortical encephalitis along with positive MOG-IgG seropositivity via cell-based assay (CBA). This evidence concerns the gene MOG and optic neuritis.